• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

描述黏多糖贮积症 VII 型伊比利亚队列的分子和临床特征。

Description of the molecular and clinical characteristics of the mucopolysaccharidosis type VII Iberian cohort.

机构信息

Unidad de Dismorfología Y Metabolismo, Hospital Universitario Virgen del Rocío, Avda. Manuel Siurot, s/n, 41013, Seville, Spain.

Fundació Hospital Sant Joan de Deu, Esplugues/Clínica Teknon, Barcelona, Spain.

出版信息

Orphanet J Rare Dis. 2021 Oct 22;16(1):445. doi: 10.1186/s13023-021-02063-1.

DOI:10.1186/s13023-021-02063-1
PMID:34686181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8532367/
Abstract

BACKGROUND

Mucopolysaccharidosis type VII (Sly syndrome) is an ultra-rare neurometabolic disorder caused by inherited deficiency of the lysosomal enzyme β-glucuronidase. Precise data regarding its epidemiology are scarce, but birth prevalence is estimated to vary from 0.02 to 0.24 per 100,000 live births. The clinical course and disease progression are widely heterogeneous, but most patients have been reported to show signs such as skeletal deformities or cognitive delay. Additionally, detection criteria are not standardized, resulting in delayed diagnosis and treatment.

METHODS

We present a cohort of 9 patients with mucopolysaccharidosis VII diagnosed in the Iberian Peninsula, either in Spain or Portugal. The diagnostic approach, genetic studies, clinical features, evolution and treatment interventions were reviewed.

RESULTS

We found that skeletal deformities, hip dysplasia, hydrops fetalis, hepatosplenomegaly, hernias, coarse features, respiratory issues, and cognitive and growth delay were the most common features identified in the cohort. In general, patients with early diagnostic confirmation who received the appropriate treatment in a timely manner presented a more favorable clinical evolution.

CONCLUSIONS

This case series report helps to improve understanding of this ultra-rare disease and allows to establish criteria for clinical suspicion or diagnosis, recommendations, and future directions for better management of patients with Sly syndrome.

摘要

背景

黏多糖贮积症 VII 型(Sly 综合征)是一种由溶酶体酶β-葡糖苷酸酶遗传性缺乏引起的超罕见神经代谢疾病。关于其流行病学的确切数据很少,但据估计,其出生率从每 10 万活产儿 0.02 到 0.24 不等。其临床过程和疾病进展广泛存在异质性,但大多数患者都有骨骼畸形或认知延迟等迹象。此外,检测标准尚未标准化,导致诊断和治疗延迟。

方法

我们报告了在伊比利亚半岛(西班牙或葡萄牙)确诊的 9 例黏多糖贮积症 VII 型患者的队列。回顾了诊断方法、基因研究、临床特征、演变和治疗干预措施。

结果

我们发现骨骼畸形、髋关节发育不良、胎儿水肿、肝脾肿大、疝气、粗糙面容、呼吸问题、认知和生长迟缓是该队列中最常见的特征。一般来说,早期诊断并及时接受适当治疗的患者具有更有利的临床转归。

结论

本病例系列报告有助于加深对这种超罕见疾病的认识,并为临床怀疑或诊断、建议以及未来更好地管理 Sly 综合征患者的方向确立标准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a1/8532367/51217427eb5f/13023_2021_2063_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a1/8532367/9306754f6642/13023_2021_2063_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a1/8532367/51217427eb5f/13023_2021_2063_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a1/8532367/9306754f6642/13023_2021_2063_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a1/8532367/51217427eb5f/13023_2021_2063_Fig2_HTML.jpg

相似文献

1
Description of the molecular and clinical characteristics of the mucopolysaccharidosis type VII Iberian cohort.描述黏多糖贮积症 VII 型伊比利亚队列的分子和临床特征。
Orphanet J Rare Dis. 2021 Oct 22;16(1):445. doi: 10.1186/s13023-021-02063-1.
2
Mucopolysaccharidosis type VII (Sly syndrome) - What do we know?黏多糖贮积症VII型(斯利综合征)——我们了解些什么?
Mol Genet Metab. 2024 Mar;141(3):108145. doi: 10.1016/j.ymgme.2024.108145. Epub 2024 Jan 17.
3
Clinical course of sly syndrome (mucopolysaccharidosis type VII).斯利综合征(黏多糖贮积症VII型)的临床病程。
J Med Genet. 2016 Jun;53(6):403-18. doi: 10.1136/jmedgenet-2015-103322. Epub 2016 Feb 23.
4
Mucopolysaccharidosis VII in Brazil: natural history and clinical findings.巴西黏多糖贮积症 VII 型:自然病史和临床发现。
Orphanet J Rare Dis. 2021 May 22;16(1):238. doi: 10.1186/s13023-021-01870-w.
5
Pathway to diagnosis and burden of illness in mucopolysaccharidosis type VII - a European caregiver survey.黏多糖贮积症 VII 型的诊断途径和疾病负担 - 一项欧洲照顾者调查。
Orphanet J Rare Dis. 2019 Nov 14;14(1):254. doi: 10.1186/s13023-019-1233-z.
6
Mucopolysaccharidosis type VII as a cause of recurrent non-immune hydrops fetalis.VII型黏多糖贮积症作为复发性非免疫性胎儿水肿的一个病因。
J Perinat Med. 2003;31(6):535-7. doi: 10.1515/JPM.2003.083.
7
The first mucopolysaccharidosis type VII in a Taiwanese girl: A case report and review of the literature.首例台湾地区黏多糖贮积症 VII 型患者:病例报告与文献复习。
J Formos Med Assoc. 2022 Mar;121(3):712-717. doi: 10.1016/j.jfma.2021.07.024. Epub 2021 Aug 20.
8
Clinical manifestations and genetic mutation analysis of patients with mucopolysaccharidosis type VII in China.中国黏多糖贮积症 VII 型患者的临床表现和基因突变分析。
Eur J Med Genet. 2024 Apr;68:104933. doi: 10.1016/j.ejmg.2024.104933. Epub 2024 Mar 3.
9
Oral manifestations in patients and dogs with mucopolysaccharidosis Type VII.黏多糖贮积症 VII 型患者和犬的口腔表现。
Am J Med Genet A. 2019 Mar;179(3):486-493. doi: 10.1002/ajmg.a.61034. Epub 2019 Jan 17.
10
A new case report of severe mucopolysaccharidosis type VII: diagnosis, treatment with haematopoietic cell transplantation and prenatal diagnosis in a second pregnancy.一个严重黏多糖贮积症 VII 型的新病例报告:诊断、造血干细胞移植治疗以及第二胎的产前诊断。
Ital J Pediatr. 2018 Nov 16;44(Suppl 2):128. doi: 10.1186/s13052-018-0566-x.

引用本文的文献

1
Analysis of genomic ancestry and characterization of a new variant in MPS type VII.黏多糖贮积症VII型的基因组血统分析及一种新变体的特征描述。
Orphanet J Rare Dis. 2025 Apr 25;20(1):198. doi: 10.1186/s13023-025-03593-8.
2
Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies.推进中枢神经系统治疗:通过基于纳米颗粒的基因和酶替代疗法改善神经系统疾病。
Int J Nanomedicine. 2025 Feb 4;20:1443-1490. doi: 10.2147/IJN.S457393. eCollection 2025.
3
Post-tonsillectomy outcomes in children with mucopolysaccharidosis and obstructive sleep apnea.

本文引用的文献

1
Mucopolysaccharidosis VII in Brazil: natural history and clinical findings.巴西黏多糖贮积症 VII 型:自然病史和临床发现。
Orphanet J Rare Dis. 2021 May 22;16(1):238. doi: 10.1186/s13023-021-01870-w.
2
Pathway to diagnosis and burden of illness in mucopolysaccharidosis type VII - a European caregiver survey.黏多糖贮积症 VII 型的诊断途径和疾病负担 - 一项欧洲照顾者调查。
Orphanet J Rare Dis. 2019 Nov 14;14(1):254. doi: 10.1186/s13023-019-1233-z.
3
First Report of a Patient with MPS Type VII, Due to Novel Mutations in , Who Underwent Enzyme Replacement and Then Hematopoietic Stem Cell Transplantation.
儿童扁桃体切除术后黏多糖贮积症伴阻塞性睡眠呼吸暂停的结局。
J Otolaryngol Head Neck Surg. 2023 Dec 24;52(1):87. doi: 10.1186/s40463-023-00685-y.
4
Diagnosis and Emerging Treatment Strategies for Mucopolysaccharidosis VII (Sly Syndrome).黏多糖贮积症VII型(斯利综合征)的诊断与新兴治疗策略
Ther Clin Risk Manag. 2022 Dec 22;18:1143-1155. doi: 10.2147/TCRM.S351300. eCollection 2022.
MPS VII 型患者的首例报告,其致病原因为 中的新型突变,该患者接受了酶替代治疗,随后进行了造血干细胞移植。
Int J Mol Sci. 2019 Oct 28;20(21):5345. doi: 10.3390/ijms20215345.
4
Vestronidase Alfa: A Review in Mucopolysaccharidosis VII.威斯塔霉素α:黏多糖贮积症 VII 型治疗药物的综述
BioDrugs. 2019 Apr;33(2):233-240. doi: 10.1007/s40259-019-00344-7.
5
Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials.药代动力学和药效学建模以优化 Vestronidase Alfa 的剂量,Vestronidase Alfa 是一种酶替代疗法,用于治疗黏多糖贮积症 VII 型患者:三项试验的结果。
Clin Pharmacokinet. 2019 May;58(5):673-683. doi: 10.1007/s40262-018-0721-y.
6
Haematopoietic stem cell transplantation for mucopolysaccharidosis type VII: A case report.黏多糖贮积症VII型的造血干细胞移植:一例报告
Pediatr Transplant. 2018 Nov;22(7):e13278. doi: 10.1111/petr.13278. Epub 2018 Aug 9.
7
Epidemiology of mucopolysaccharidoses.黏多糖贮积症的流行病学
Mol Genet Metab. 2017 Jul;121(3):227-240. doi: 10.1016/j.ymgme.2017.05.016. Epub 2017 May 26.
8
A selective screening program for the early detection of mucopolysaccharidosis: Results of the FIND project - a 2-year follow-up study.一项用于黏多糖贮积症早期检测的选择性筛查项目:FIND项目的结果——一项为期2年的随访研究。
Medicine (Baltimore). 2017 May;96(19):e6887. doi: 10.1097/MD.0000000000006887.
9
Quantitative clinical characteristics of 53 patients with MPS VII: a cross-sectional analysis.MPS VII 患者 53 例的临床定量特征:横断面分析。
Genet Med. 2017 Sep;19(9):983-988. doi: 10.1038/gim.2017.10. Epub 2017 Apr 6.
10
Anaesthetic implications of the changing management of patients with mucopolysaccharidosis.黏多糖贮积症患者管理方式变化的麻醉影响
Anaesth Intensive Care. 2016 Nov;44(6):660-668. doi: 10.1177/0310057X1604400612.